REDWOOD CITY, Calif. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Kriya Therapeutics, Inc., a fully integrated gene therapy company pioneering novel technologies and therapeutics, today announced a $270 Million Series C financing. The financing was led by Patient Square Capital, with participation from Bluebird Ventures, CAM Capital, Dexcel Pharma, Foresite Capital, JDRF T1D Fund, Lightswitch Capital, Narya Capital, QVT, Transhuman Capital, and other undisclosed investors. Proceeds from this financing will support the advancement of Kriyas pipeline and continued scaling of its engineering, manufacturing, and computational platforms.
Kriya has established an ecosystem for delivering best-in-class technologies and medicines in gene therapy, with core business units in technology, manufacturing, R&D, and therapeutics. By leveraging its proprietary computational platform, in-house manufacturing infrastructure, and rational design toolkit, the company is uniquely positioned to bring potentially transformative gene therapies to a broad range of diseases.
We believe gene therapy has the potential to redefine medicine over the next decade. However, the field has been constrained by technological and operational challenges that make it difficult and expensive to deliver new products, said Shankar Ramaswamy, M.D., Co-Founder and Chief Executive Officer of Kriya. Kriya was founded to address the primary problems limiting the field, and I am proud of the progress we have made to date. This financing will support our continued growth as we advance our diverse pipeline into the clinic and further scale our core platforms, to achieve our ultimate vision of expanding the reach and unlocking the full potential of gene therapy as a modality.
In recent months, Kriya has achieved several milestones across key parts of its business. The company significantly expanded its pipeline through its internal R&D efforts, as well as through acquisitions and partnerships with leading companies and academic institutions. In addition, Kriya operationalized its state-of-the-art, scalable GMP manufacturing infrastructure in Research Triangle Park, North Carolina to support in-house production from early through late phase development. This infrastructure also empowers the development and implementation of novel technologies and processes that enable consistent, large-scale manufacturing. Kriya has also scaled SIRVE, its machine learning-enabled technology and cloud computing architecture, to support the integration of large datasets generated by the companys high throughput screening, next generation sequencing, and algorithmic data mining platforms.
Kriya has made tremendous strides over the past few years, attracting world-class talent, expanding its pipeline, and scaling the infrastructure necessary to unlock the full potential of gene therapy, said Jim Momtazee, Managing Partner of Patient Square Capital and Kriya Board Member. We believe the company has the potential to be the clear leader in the evolving gene therapy field, consistent with Patient Square Capitals focus to build and support category leading companies in health care.
About Kriya
Kriya is a fully integrated gene therapy company on a mission to revolutionize how gene therapies are designed, developed, and manufactured with a goal of improving speed to market and reducing cost. The company leverages its proprietary computational engine, in-house manufacturing infrastructure, and integrated design platform to engineer products with the potential to transform the treatment of a broad range of diseases. Kriyas team includes scientific pioneers with decades of experience in product development, complex manufacturing, and computational engineering.
The company has established an ecosystem for delivering best-in-class technologies and medicines, with core business units in technology, manufacturing, R&D, and therapeutics. Kriyas product pipeline addresses diseases of high unmet need with therapeutic area divisions in ophthalmology, oncology, rare disease, and chronic disease, each led by industry veterans with a track record of advancing products from concept through commercialization. Built upon this foundation, Kriya achieves the scale needed to drive transformational improvements in the engineering, production, and translation of gene therapies. For more information, please visit http://www.kriyatx.com and follow on LinkedIn.
- Green Goblin, the Hasty Transhumanist - Walter Bradley Center for Natural and Artificial Intelligence - April 18th, 2024 [April 18th, 2024]
- Your Favorites Radio | All your favorite songs and artists - iHeartRadio - November 15th, 2023 [November 15th, 2023]
- Can't Miss Indie Press Speculative Fiction for November and ... - tor.com - November 15th, 2023 [November 15th, 2023]
- What is posthumanism? And should you worry about it? - Aleteia - November 8th, 2023 [November 8th, 2023]
- Ray Kurzweil Predicts: The Singularity by 2045 - Discovery Institute - November 8th, 2023 [November 8th, 2023]
- A Conversation About God | Dr. John Lennox - The Daily Wire - November 8th, 2023 [November 8th, 2023]
- 'Billions' of megalomaniacal humanoids could, one day, ambush the ... - Robotics and Automation News - November 8th, 2023 [November 8th, 2023]
- 3rd Annual ELTS Graduate Student Conference: Speculative ... - UCLA International Institute - November 8th, 2023 [November 8th, 2023]
- Donna Haraway's Children: Meet the Dynamic Young Artists Who ... - Cultured Magazine - November 8th, 2023 [November 8th, 2023]
- Scary Movies for Anarchists to Watch at the End of the World - CounterPunch - November 8th, 2023 [November 8th, 2023]
- Data Summit 2023: shaping the future of AI and Data - Scottish Business News - November 8th, 2023 [November 8th, 2023]
- Ghost Work and the Enduring Necessity of Human Labor - Walter Bradley Center for Natural and Artificial Intelligence - November 8th, 2023 [November 8th, 2023]
- Alien TV series: Plot, cast, release date and everything we know - Yahoo Lifestyle UK - July 27th, 2023 [July 27th, 2023]
- Traditional Perspectives on Philosophy - pt. 1: Voluntarism - OnePeterFive - July 27th, 2023 [July 27th, 2023]
- Accusations of a Government Cover-Up Dominate Congressional UFO Hearing - Decrypt - July 27th, 2023 [July 27th, 2023]
- Elon Musk Appoints Dan Hendrycks as Advisor to xAI Startup - Fagen wasanni - July 27th, 2023 [July 27th, 2023]
- Anton Vidokle on the Cinema of the Stars - Ocula Magazine - July 27th, 2023 [July 27th, 2023]
- The day the bubble burst: Akira and Japan's economic 'miracle' - Canadian Dimension - July 27th, 2023 [July 27th, 2023]
- Ex-Google engineer says humans will achieve immortality in 7 years; here's how netizens reacted - Business Today - April 6th, 2023 [April 6th, 2023]
- Super-intelligence and eternal life: transhumanism's faithful follow it ... - March 31st, 2023 [March 31st, 2023]
- Pioneering Transhumanism: a conversation with Natasha Vita-More - February 5th, 2023 [February 5th, 2023]
- 4 Problems with Transhumanism - Human Life International - February 2nd, 2023 [February 2nd, 2023]
- Transhumanism: Examining the risks, benefits, and ethical implications ... - January 25th, 2023 [January 25th, 2023]
- Noted Transhumanist Now Targeting Our Children: Whats inside Yuval ... - January 10th, 2023 [January 10th, 2023]
- Humans Will Never Colonize Mars - Gizmodo - January 10th, 2023 [January 10th, 2023]
- Ghost in the Shell (1995) - IMDb - December 28th, 2022 [December 28th, 2022]
- The Transhumanist Agenda Behind Bidens Executive Order on Advancing ... - December 28th, 2022 [December 28th, 2022]
- The Missing Plan for Alien First Contact to Pro-and-Anti-UFO Factions in U.S. Government (Planet Earth Report) - The Daily Galaxy --Great Discoveries... - November 8th, 2022 [November 8th, 2022]
- Biden Signs Executive Order Designed to Unleash "Transhumanist Hell" on ... - November 7th, 2022 [November 7th, 2022]
- Biden transhumanist executive order: We need to program biology ... - November 7th, 2022 [November 7th, 2022]
- Meaning of life - Wikipedia - November 7th, 2022 [November 7th, 2022]
- Take years off your age: this Israeli expert says its all up to you - Haaretz - November 7th, 2022 [November 7th, 2022]
- Transhumanism: advances in technology could already put evolution into ... - October 30th, 2022 [October 30th, 2022]
- Bidens Executive Order Designed to Release Transhumanist Hell on ... - October 30th, 2022 [October 30th, 2022]
- Biden's Executive Order Advances Biotech-Transhumanist Agenda ... - October 23rd, 2022 [October 23rd, 2022]
- Elon Musks Neuralink allegedly subjected monkeys to extreme suffering - October 23rd, 2022 [October 23rd, 2022]
- Doomsday bunkers, Mars and 'The Mindset': the tech bros trying to outsmart the end of the world - The Conversation Indonesia - October 8th, 2022 [October 8th, 2022]
- Is the body key to understanding consciousness? - - October 8th, 2022 [October 8th, 2022]
- Nvidia and the 3D Future of the Internet - TechNewsWorld - October 8th, 2022 [October 8th, 2022]
- I have to ask: Did anything happen to you with the 0010110 social media mystery? Are you still with us? - Alan Cross - A Journal of Musical Things - August 30th, 2022 [August 30th, 2022]
- If the US is Nineveh, Then Canada is Sodom - The Stream - August 30th, 2022 [August 30th, 2022]
- Gaming Adventures You Don't Want To Miss In 2022 - Gamesreviews - August 30th, 2022 [August 30th, 2022]
- The theory behind conspiracy - The Spectator Australia - August 30th, 2022 [August 30th, 2022]
- What is Creation? | What is Creation? - Patheos - August 30th, 2022 [August 30th, 2022]
- Transhumanism Humanity+ - August 25th, 2022 [August 25th, 2022]
- Become your true self - Freedom of Form Foundation - August 25th, 2022 [August 25th, 2022]
- Ghosts, Mummies, and Robots in Buddhism - Buddhistdoor Global - August 25th, 2022 [August 25th, 2022]
- The Biggest Threat to Humanity? Black Goo - WIRED - August 25th, 2022 [August 25th, 2022]
- You Cant Back the Murder of Alexander Dugin Then Whine About Salman Rushdie Or Attacks on American Neocons - The Stream - August 25th, 2022 [August 25th, 2022]
- Android app deals of the day: Codex of Victory, Scalak, Reminder Pro, more - 9to5Toys - August 25th, 2022 [August 25th, 2022]
- Whatever happened to transhumanism? - BioEdge - August 23rd, 2022 [August 23rd, 2022]
- Who needs religion when you've got these clowns promoting bad ideas? - Freethought Blogs - August 23rd, 2022 [August 23rd, 2022]
- The Importance of Medical Ethics Highlighted During the 75Th Anniversary of the Nuremberg Code - The Epoch Times - August 23rd, 2022 [August 23rd, 2022]
- History of a hard man: Neil Balme memoir stands out from the pack - Sydney Morning Herald - August 23rd, 2022 [August 23rd, 2022]
- Henry Kyereme: Could advances in technology undermine the future of humans? - Myjoyonline - July 7th, 2022 [July 7th, 2022]
- Iris Van Herpen Explores Life Beyond the Physical Realm for A/W 22 Couture - vmagazine.com - July 7th, 2022 [July 7th, 2022]
- Virtual Beauty, Virtual Freedom, Virtual Love: Is the Metaverse Our Future? - PRESSENZA International News Agency - July 7th, 2022 [July 7th, 2022]
- Network TV Hasn't Been The Same Since This Sci-Fi Drama Left The Air - Looper - July 4th, 2022 [July 4th, 2022]
- The myth of 'artificial intelligence' - spiked - Spiked - July 4th, 2022 [July 4th, 2022]
- Fulton Sheens July 4 Declaration of Dependence - National Catholic Register - July 4th, 2022 [July 4th, 2022]
- All Agents Defect: Espionage in the Films of David Cronenberg - CrimeReads - June 22nd, 2022 [June 22nd, 2022]
- Tune In: The Art of the Videogame Soundtrack - Highbrow Magazine - June 11th, 2022 [June 11th, 2022]
- It's been 10 years since Prometheus, what can the reboot teach the Alien TV show? - TechRadar - June 11th, 2022 [June 11th, 2022]
- Religious Transhumanism 11: What about the body? | cybernetic immortality - Patheos - May 28th, 2022 [May 28th, 2022]
- Elon Musk is promoting transhumanism as part of Agenda 2030. - Logically - May 28th, 2022 [May 28th, 2022]
- PEW and transhumanism: Public has mixed concerns about arriving era of Artificial Intelligence (AI) and human enhancement - Genetic Literacy Project - May 28th, 2022 [May 28th, 2022]
- David Cronenberg Gets Back to Basics in Crimes of the Future - Vanity Fair - May 28th, 2022 [May 28th, 2022]
- Painting on Another Plane: Mandy Cao - MutualArt.com - May 28th, 2022 [May 28th, 2022]
- Have Authoritarians Used 1984 as a Handbook? - Verve Times - May 28th, 2022 [May 28th, 2022]
- How to Grow and Forage Without Owning Land - Verve Times - May 28th, 2022 [May 28th, 2022]
- Meet the Human Battery, a New Source of "Green" Energy - Verve Times - May 20th, 2022 [May 20th, 2022]
- This Years Venice Biennale is Full of Surrealism and Stark Reminders - Yahoo News - May 20th, 2022 [May 20th, 2022]
- Is it possible to transplant heads? - BioEdge - May 20th, 2022 [May 20th, 2022]
- The Best Movies Of 2022 So Far - /Film - May 20th, 2022 [May 20th, 2022]
- Future of work: the top careers of the next decade - The Age - May 17th, 2022 [May 17th, 2022]
- Five Standout Films Coming To Cannes This Year [Trailers] - 2oceansvibe News - May 17th, 2022 [May 17th, 2022]
- Cannes 2022: 10 movies to watch out for in this years festival - The Guardian - May 17th, 2022 [May 17th, 2022]
- On the Gnostic Ironies of Poets Nathaniel Mackey and Fanny Howe - Literary Hub - May 17th, 2022 [May 17th, 2022]
- Dismantling the Transhumanist Agenda - The Post & Email - May 6th, 2022 [May 6th, 2022]
- Endowed by their Creator: exploring human rights in the age of transhumanism - The Sociable - May 6th, 2022 [May 6th, 2022]